Keyphrases
Immunosuppression
100%
Adenovirus
100%
Recombinant
100%
Antigen-specific
100%
Intestinal mucosa
100%
Human Adenovirus (HAdV)
100%
Anaphylactic Shock
100%
Mucosal Tolerance
100%
Allergy
50%
Diarrhea
50%
Mouse Model
50%
Delivery System
50%
Mucosal Vaccine
50%
Life-threatening
50%
Recombinant Adenovirus
50%
Intestine
50%
Vaccine Carrier
50%
Ovalbumin
50%
Current Therapies
50%
Delayed Hypersensitivity
50%
Allergic Reaction
50%
Peyer's Patches
50%
Ileum
50%
Vector-based
50%
Anaphylaxis
50%
Systemic Anaphylaxis
50%
Replication-defective
50%
Allergen-specific
50%
Systemic Immunity
50%
Vaccine Administration
50%
Vector Distribution
50%
Immunoreaction
50%
Intestinal mucosal Immunity
50%
New Allergen
50%
Sublingual Immunotherapy
50%
Enteric Adenovirus
50%
Human Adenovirus Type 5
50%
Ad Vector
50%
Immunology and Microbiology
Immunosuppression
100%
Hypersensitive Response
100%
Serotype
100%
Adenoviridae
100%
Allergen
100%
Antigen Specificity
100%
Human Adenovirus C
100%
Intestine Mucosa
100%
Anaphylaxis
100%
Peyer's Patch
50%
Systemic Immunity
50%
Mouse Model
50%
Intestine
50%
Delayed Hypersensitivity
50%
Human Adenovirus 5
50%
Systemic Anaphylaxis
50%
Immunotherapy
50%
Ileum
50%
Medicine and Dentistry
Anaphylaxis
100%
Human Adenovirus C
100%
Intraduodenal Drug Administration
100%
Recombinant
75%
Antigen Specificity
50%
Immunosuppressive Treatment
50%
Allergic Response
50%
Adenoviridae
50%
Intestine Mucosa
50%
Serotype
50%
Allergen
50%
Oral Drug Administration
25%
Diarrhea
25%
Delayed Hypersensitivity
25%
Human Adenovirus 5
25%
Ileum
25%
Mucosal Vaccine
25%
Systemic Immunity
25%
Intestine
25%
Systemic Anaphylaxis
25%
Immunotherapy
25%
Peyer's Patch
25%
Ovalbumin
25%
Pharmacology, Toxicology and Pharmaceutical Science
Recombinant
100%
Human Adenovirus C
100%
Anaphylaxis
100%
Adenoviridae
66%
Allergic Reaction
66%
Allergen
66%
Mouse Model
33%
Mucosal Vaccine
33%
Diarrhea
33%
Ovalbumin
33%
Delayed Hypersensitivity
33%
Human Adenovirus 5
33%
Systemic Anaphylaxis
33%
Immunotherapy
33%
Ileum
33%